Li Li

Medical Affairs and Pharmacovigilance, Pharmaceuticals, Bayer AG, Berlin, Germany;

Articles by Li Li

Dual-pathway Inhibition with Low-dose Aspirin and Rivaroxaban versus Aspirin Monotherapy in Patients with Coronary Artery Disease and Peripheral Artery Disease: Systematic Literature Review and Meta-analysis

Dirk Sibbing, Michael J Blaha, Rajinder Chawla, et al

Published:

Citation: European Cardiology Review 2024;19:e01.

DOI:

https://doi.org/10.15420/ecr.2023.40